Margaret Kennedy, PhD

Current Position: Consultant, ClearView HealthCare Partners
GSK Student
Email
[email protected]
Dissertation
Investigating Transcriptional Dyregulation in Disease Through Genetic Engineering and Therapeutic Inhibition
Mentor
Scott W. Lowe, PhD
Start Year
2019
End Year
2026
Education
BS, The College of New Jersey; Cancer Biology

Fellowships

  • Ruth L. Kirschstein Predoctoral Individual National Research Service Fellowship, NIH National Cancer Institute (2022-2025)
Publications

Li X, Huang CH, Sánchez-Rivera FJ, Kennedy MC, Tschaharganeh DF, Morris JP 4th, Montinaro A, O’Rourke KP, Banito A, Wilkinson JE, Chen CC, Ho YJ, Dow LE, Tian S, Luan W, de Stanchina E, Zhang T, Gray NS, Walczak H, Lowe SW.(2022) A preclinical for assessing antitumor effects and systemic toxicities of cancer drug targets. Proc Natl Acd Sci USA.

Kennedy MC, Lowe SW. (2022) Mutant p53: it’s not all one and the same. (2022) Cell Death Differ Epub

Sánchez-Rivera FJ, Diaz BJ, Kastenhuber ER, Schmidt H, Katti A, Kennedy M, Tem V, Ho YJ, Leibold J, Paffenholz SV, Barriga FM, Chu K, Goswami S, Wuest AN, Simon JM, Tsanov KM, Chakravarty D, Zhang H, Leslie CS, Lowe SW, Dow LE; Base editing sensor libraries for high- throughput engineering and functional analysis of cancer-associated single nucleotide variants.; Nature biotechnology; 2022; 40(6):862-873; PMC9232935;

View a full listing of Margaret Kennedy’s journal articles.